Stocks and Investing
Stocks and Investing
Tue, March 12, 2024
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
[ Tue, Mar 12th 2024
] - WOPRAI
Emily Bodnar Reiterated (SLRN) at Strong Buy and Held Target at $30 on, Mar 12th, 2024
Emily Bodnar of HC Wainwright & Co., Reiterated "Acelyrin, Inc." (SLRN) at Strong Buy and Held Target at $30 on, Mar 12th, 2024.
Emily has made no other calls on SLRN in the last 4 months.
There are 4 other peers that have a rating on SLRN. Out of the 4 peers that are also analyzing SLRN, 3 agree with Emily's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Derek Archila of "Wells Fargo" Initiated at Hold and Held Target at $11 on, Wednesday, December 13th, 2023
- Samantha Semenkow of "Citigroup" Initiated at Hold and Held Target at $8 on, Friday, December 8th, 2023
- Vikram Purohit of "Morgan Stanley" Maintained at Hold with Decreased Target to $13 on, Wednesday, November 29th, 2023
This is the rating of the analyst that currently disagrees with Emily
- Akash Tewari of "Jefferies" Maintained at Strong Buy with Decreased Target to $12 on, Tuesday, November 28th, 2023
Contributing Sources